Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q3 2021 Result - Earnings Call Transcript

Adamis Pharmaceuticals Corporation (ADMP) Q3 2021 Earnings Conference Call November 22, 2021 5:00 AM ET

Company Participants

Robert Uhl – Chief Accounting Officer
Dennis Carlo – CEO
Ron Moss – Chief Medical Officer
David Marguglio – Chief Business Officer
David Benedicto – CFO

Conference Call Participants

Elliot Wilbur – Raymond James

Operator

Greetings. Welcome to the Adamis Pharmaceuticals Corp Q3, 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions ] Please note, this conference is being recorded. I will now turn the conference over to your host, Mr. Robert Uhl, will you may begin.

Robert Uhl

Thank you, Operator. Good afternoon, everyone. And welcome to the Adamis Pharmaceuticals Third Quarter 2021 Financial Results and Corporate Update Conference Call. Thank you for joining us today for the update and welcome to our shareholders, analysts and anyone interested in Adamis. Joining me today is Adamis ' President and CEO, Dr. Dennis J. Carlo, Chief Medical Officer, Dr. Ron Moss, Chief Business Officer, David Marguglio, and Adamis ' recently-named Chief Financial Officer, David Benedicto. The format for this call will consist of prepared remarks from management followed by Q&A.

This call is being webcast and will be available for replay in the Investors section of our website, adamispharmaceuticals.com. In today's call, we will make certain forward-looking statements regarding our business based on current expectations and current information. Those statements speak only as of today and, except as required by law, we do not assume any duty to update in the future any forward-looking statements made today. Of course, any forward-looking statements involve risks and uncertainties and our actual results could differ materially from those anticipated by any forward-looking statements that we make today.

Additional